Stockreport

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial [Yahoo! Finance]

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF Company will summarize topline data from the FORESEE clinical trial planned for presentation at the SNO/ASCO Meeting in August 2024 Management call scheduled for Th [Read more]